chr22-19356246-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_003325.4(HIRA):āc.2439A>Gā(p.Leu813=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000604 in 1,614,056 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0035 ( 3 hom., cov: 32)
Exomes š: 0.00031 ( 2 hom. )
Consequence
HIRA
NM_003325.4 synonymous
NM_003325.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0800
Genes affected
HIRA (HGNC:4916): (histone cell cycle regulator) This gene encodes a histone chaperone that preferentially places the variant histone H3.3 in nucleosomes. Orthologs of this gene in yeast, flies, and plants are necessary for the formation of transcriptionally silent heterochomatin. This gene plays an important role in the formation of the senescence-associated heterochromatin foci. These foci likely mediate the irreversible cell cycle changes that occur in senescent cells. It is considered the primary candidate gene in some haploinsufficiency syndromes such as DiGeorge syndrome, and insufficient production of the gene may disrupt normal embryonic development. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 22-19356246-T-C is Benign according to our data. Variant chr22-19356246-T-C is described in ClinVar as [Benign]. Clinvar id is 727503.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.08 with no splicing effect.
BS2
High AC in GnomAd4 at 526 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HIRA | NM_003325.4 | c.2439A>G | p.Leu813= | synonymous_variant | 20/25 | ENST00000263208.5 | NP_003316.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HIRA | ENST00000263208.5 | c.2439A>G | p.Leu813= | synonymous_variant | 20/25 | 1 | NM_003325.4 | ENSP00000263208 | P1 | |
HIRA | ENST00000340170.8 | c.1818A>G | p.Leu606= | synonymous_variant | 16/21 | 1 | ENSP00000345350 | |||
C22orf39 | ENST00000509549.5 | c.*2315A>G | 3_prime_UTR_variant, NMD_transcript_variant | 21/24 | 2 | ENSP00000424903 |
Frequencies
GnomAD3 genomes AF: 0.00345 AC: 525AN: 152150Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
525
AN:
152150
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000847 AC: 213AN: 251436Hom.: 0 AF XY: 0.000611 AC XY: 83AN XY: 135894
GnomAD3 exomes
AF:
AC:
213
AN:
251436
Hom.:
AF XY:
AC XY:
83
AN XY:
135894
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000307 AC: 449AN: 1461788Hom.: 2 Cov.: 31 AF XY: 0.000257 AC XY: 187AN XY: 727214
GnomAD4 exome
AF:
AC:
449
AN:
1461788
Hom.:
Cov.:
31
AF XY:
AC XY:
187
AN XY:
727214
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00345 AC: 526AN: 152268Hom.: 3 Cov.: 32 AF XY: 0.00349 AC XY: 260AN XY: 74454
GnomAD4 genome
AF:
AC:
526
AN:
152268
Hom.:
Cov.:
32
AF XY:
AC XY:
260
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 13, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | HIRA: BP4, BP7, BS1, BS2 - |
HIRA-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 11, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at